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Abstract
Background: Data regarding coronavirus disease 2019 (COVID-19) cases and outcomes in infants are sparse
compared to older pediatric and adult populations.
Case presentation: We present a three-week-old full-term male with a history of mild hypoxic ischemic
encephalopathy (HIE) who was admitted as an inpatient twice for episodes of apnea and perioral cyanosis. The
patient tested positive for COVID-19 and negative for other common respiratory viruses at both admissions.
Conclusions: To our knowledge, this is the first report of apnea and perioral cyanosis associated with COVID-19 in
an infant. This case highlights a previously undocumented COVID-19 presentation and suggests that even mildly
symptomatic infants warrant viral diagnostic testing in an effort to prevent further spread of the disease.
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Background
The world is in the midst of a global pandemic due to
COVID-19, an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Due
to its novelty there is still limited knowledge about its
natural history, and data regarding its effect on pediatric
patients is particularly sparse compared to adult patients
[1]. From what is currently understood, in the pediatric
population, particularly in younger children, morbidity
and mortality rates are notably lower than the adult
population [2]. The most common clinical features of
COVID-19 in children are fever, cough, and fatigue,
which are symptoms also associated with numerous
common respiratory tract infections. Younger patients
usually require only supportive care and generally re-
cover fully within two weeks of symptom onset [3–5],
though there have been multiple anecdotal reports of
COVID-19 related deaths in infants. We present a case
of apnea and perioral cyanosis, initially worked up as a
brief resolved unexplained event (BRUE), associated with
COVID-19.
Case presentation
A 25-day-old full-term male infant with a history of mild
HIE was admitted initially for work-up of BRUE. His
guardians described a single episode three days prior to
presentation during which the patient stopped breathing
and developed perioral cyanosis for approximately 3–4 s
while sleeping, which resolved with mild stimulation and
waking. Associated symptoms included nasal congestion
and rhinorrhea. Multiple family members had been ex-
periencing fevers, cough, and congestion starting the
week prior. The patient’s only additional medical history
was respiratory distress at birth requiring 24 h of positive
pressure ventilation, and episodes of desaturation during
his first six days of life which were attributed to possible
mild laryngomalacia.
Vital signs were within normal limits. Physical exam
was without abnormal findings. A nasopharyngeal and
oropharyngeal polymerase chain reaction (PCR) test for
SARS-CoV-2 and a respiratory viral panel (RVP) PCR
were collected. Continuous pulse oximetry overnight
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was normal, and he was discharged home the subse-
quent morning with instructions to presumptively quar-
antine while RVP and COVID-19 testing were pending.
Shortly after discharge, his COVID-19 PCR resulted
positive and RVP resulted negative.
Three weeks after his initial presentation, at 45 days of
life, the patient was brought back to the hospital after his
guardians that day noted new recurrent episodes of apnea
and perioral cyanosis, intermittent stridor, and abnormal
head and eye movements. Physical exam was unchanged
from his prior admission except for intermittent inspira-
tory stridor noted while the patient was asleep. A basic
metabolic panel was within normal limits and repeat
COVID-19 and RVP PCR were positive and negative, re-
spectively. He was evaluated by a speech therapist who did
not feel he was at risk for aspiration. Neurology was con-
sulted, and after reviewing his prior normal electroen-
cephalograms and non-concerning brain MRI felt that, in
the context of his mild HIE diagnosis and age-appropriate
movements, his history was not consistent with seizures.
No further apneic or cyanotic episodes were noted, and
vital signs and pulse oximetry remained stable, so he was
discharged within 24 h of admission with scheduled out-
patient neurology and pulmonology follow-ups.
Discussion and conclusion
Data about COVID-19 in the infant population is scarce.
Less than 1% of patients in a review of over 72,000 cases
from China were younger than 10 years of age, and less
than 20% of a pediatric subset were younger than 1 year
of age [6, 7]. There is contradictory evidence regarding
vertical transmission of COVID-19 between infected
mothers and newborns, though the current consensus is
that vertical transmission is unlikely to occur [8, 9]. Symp-
toms in this age group vary as with older age groups. A
case series of nine hospitalized patients under the age of
one noted that most hospitalized patients were symptom-
atic with fever and upper respiratory symptoms [10]. An-
other reported case described a 55-day-old infant who
developed more severe symptoms, including pneumonia,
and demonstrated evidence of liver and cardiac injury
[11].
In younger populations, viral load may persist for
weeks regardless of symptoms, as case reports have
noted persistently positive PCR tests even in asymptom-
atic patients, including in a well 6-month-old who tested
positive for 16 days [12]. As our patient’s immediate
family members were sick one week prior to the onset of
his symptoms, his family was the likely source from
which he contracted the virus. He tested positive on ad-
mission for both hospitalizations via PCR testing, with
21 days between the two tests.
Our patient’s presentation, initially for an isolated epi-
sode of perioral cyanosis and apnea, was at first
attributed to a BRUE. A BRUE is defined as an event
lasting less than one minute without an identifiable ex-
planation and with full resolution of symptoms, in an in-
fant less than one year of age, and symptoms can
include cyanosis [13]. Past research has found a strong
correlation between apparent life-threatening events, a
less-specific diagnosis that has been replaced by the term
“BRUE,” and a positive respiratory viral infection test
[13]. However, given his recurrence of symptoms and
new onset of stridor in the setting of a persistently posi-
tive COVID-19 PCR, his symptoms are more likely to be
directly due to his infection by SARS-CoV-2. Further-
more, the recurrence of symptoms after a prolonged
asymptomatic period indicates this patient’s infection
appears to have followed an atypical course.
Despite increasing evidence demonstrating children
have more mild presentations and better outcomes in
COVID-19 infections, there is limited documentation of
individual cases, especially infants, in the medical litera-
ture. Since children appear to most commonly present
asymptomatically or mildly symptomatic, they have the
potential to serve as undetected vectors of the disease as
cities and countries start to loosen restrictions on com-
merce and socialization. Given the lack of universal test-
ing infrastructure worldwide, the implication therefore
may be to focus on opportunities to test these patients
whenever possible. With disease modeling estimating
continued COVID-19 infection in the years ahead, our
case highlights the need for clinicians to consider more
subtle presentations in infants such as brief episodes of
apnea, cyanosis, and stridor as potential catalysts to
prompt testing for SARS-CoV-2 infection, caregiver test-
ing, and/or recommending quarantine protocol.
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